Literature DB >> 6812168

The use of prostacyclin in the separation from plasma and washing of human platelets.

J R Vargas, M Radomski, S Moncada.   

Abstract

A new method for the separation from plasma and washing of human platelets is described. The use of prostacyclin (PGI2) throughout the procedure prevents the activation of platelets. The method allows a 60-70% yield of platelets from PRP. The platelet sensitivity to ADP, collagen, adrenaline, arachidonic acid and thrombin is the same as in PRP. The platelet suspension is stable for long periods and the reactivity to aggregating agents remains unchanged for periods greater than 48 h when platelets are stored at 4 degrees C.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812168     DOI: 10.1016/0090-6980(82)90135-6

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  19 in total

1.  A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets.

Authors:  D L Nunn; S P Watson
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

2.  Platelet-activating factor may participate in signal transduction processes in rabbit leukocytes.

Authors:  A G Stewart; T Harris
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.

Authors:  G Grigoriadis; A G Stewart
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

4.  Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia.

Authors:  Roberta d'Emmanuele di Villa Bianca; Emma Mitidieri; Matteo N D Di Minno; Nicholas S Kirkby; Timothy D Warner; Giovanni Di Minno; Giuseppe Cirino; Raffaella Sorrentino
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

5.  Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

6.  Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages.

Authors:  A G Stewart; W A Phillips
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

7.  Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.

Authors:  A G Stewart; T Harris; M De Nichilo; A F Lopez
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

8.  The synergism of hydrogen peroxide with plasma S-nitrosothiols in the inhibition of platelet activation.

Authors:  K M Naseem; S Chirico; B Mohammadi; K R Bruckdorfer
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

9.  The effect of low-density lipoproteins on the synthesis of cyclic nucleotides induced by prostacyclin in isolated platelets.

Authors:  K R Bruckdorfer; S Buckley; D G Hassall
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

10.  Blood plasma influences anti-aggregatory potency of prostaglandins: effect of albumin.

Authors:  G Kobzar; V Mardla; I Järving; N Samel
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.